Mounjaro (Tirzepatide)

We don’t carry this product.

Sign up to get notified if we do in the future.

Product Details


Note: This is the Canadian version of Mounjaro that comes packaged in vials rather than injector pens and it is different than the one used for the American version of Mounjaro. This product should be stored in the refrigerator before use.

Mounjaro is a prescription Type 2 diabetes treatment medication administered as a subcutaneous injection once a week. Semaglutide is the active ingredient in this Mounjaro and part of the incretin memetic (GLP-1rA) class of drugs for diabetes management. It binds to GLP-1 receptors and stimulates pancreatic insulin release, plus improving blood sugar absorption by cells so less remains in the bloodstream, and limit the production of sugar.

Mounjaro also lowers the rate at which food leaves the stomach and this means blood sugar is less likely to spike. By creating longer-lasting feelings of being full after eating Mounjaro may also contribute to enhanced weight loss. Order Mounjaro from Canada and Diabetic Online.


Mounjaro medication is administered as a subcutaneous (under skin) injection once per week.

Injection may be made into skin of your abdomen, thigh, or upper arm. If injection is into abdomen you must be injecting outside of a 2" radius around your navel.

Do not use the same location for repeated injections to avoid the chance of developing lipodystrophy. Inject in a new one of the three potential locations each time. It is common for Mounjaro users to alternate between the 3.


Prepare your pen by making sure that Semaglutide in your pen is clear and colorless

Pull off the gray base cap. Do not touch the needle

Place clear base on skin at injection site, then unlock by turning the lock ring

Press and hold for up to 10 seconds, and be listening to hear TWO clicks.

  • First click - injection started
  • Second click - injection completed

Visually confirm Mounjaro injection is complete by seeing that the gray plunger is visible in the pen.


The active ingredient in Mounjaro is Semaglutide.


Do not exceed dosage regulation of no more than ONE Mounjaro injection per week, as per the guidelines established by the pharmaceutical manufacturer. Mounjaro is not to be taken for weight loss and any weight loss will only occur if the patient engages in dietary changes and increased exercise levels as will be recommended in your prescription and the discussions you have with your doctor before you receive a prescription and switch to Mounjaro.

Tell your doctor if you have any history of liver or kidney disease, gallbladder disease, medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pancreatitis, or severe depression including suicidal or self-harm thoughts before starting on Mounjaro.

If you plan to become pregnant it is advisable to stop using Mounjaro for 2 months prior to your planned date to conceive.

Store unused Mounjaro medication in the refrigerator at 36°F to 46°F (2°C to 8°C). Once a pen is in use you can store it at room temperature 59°F to 86°F (15°C to 30°C) or in the refrigerator. Do not freeze.

Dispose of any Mounjaro pen after 56 days, even if there is some medication remaining in it.


There is the possibility of negative drug interactions between Mounjaro and other Rx or OTC medications, including atorvastatin / amlodipine / bupropion / duloxetine / furosemide / gabapentin / hydrochlorothiazide / empagliflozin / levothyroxine / lisinopril / losartan / metformin / metoprolol / omeprazole / pantoprazole / rosuvastatin / trazodone.

Tell your doctor of all medications you are currently taking before receiving a prescription and proceeding to buy Mounjaro online.

Side Effects

Side effects from Mounjaro injections are possible, and some users may experience nausea, vomiting, diarrhea, abdominal pain, constipation, heartburn, or burping. If Mounjaro side effects are experienced you may want to discontinue use and speak to your doctor again regarding diabetes pen alternatives for Type 2 diabetes treatment.

Frequently Asked Questions about Mounjaro (Tirzepatide)

What is Mounjaro?

Mounjaro is a medication approved for treating Type 2 diabetes in adults to lower blood sugar and A1C levels. It contains the active ingredient tirzepatide and works as a GIP and GLP-1 receptor agonist.

How is Mounjaro used?

Mounjaro is administered as a once-weekly subcutaneous injection, and can be injected into the thigh, abdomen, or upper arm. It should be used alongside diet and exercise for the best results.

Is Mounjaro approved for weight loss?

The active ingredient in Mounjaro, tirzepatide, is approved for weight loss under the brand name Zepbound. However, Mounjaro itself is not FDA-approved for weight loss but is used off-label for this purpose.

What are common side effects of Mounjaro?

Common side effects include nausea, diarrhea, decreased appetite, vomiting, constipation, dyspepsia, and abdominal pain. These gastrointestinal symptoms affect 5% or more patients.

Are there serious side effects of Mounjaro?

Serious side effects can include pancreatitis, kidney failure, medullary thyroid cancer, severe hypoglycemia, severe allergic reactions, vision loss, gallstones, and cholecystitis.

Can Mounjaro cause thyroid cancer?

Mounjaro and similar medications are associated with an increased incidence of medullary thyroid cancer, especially in individuals with a personal or family history of this cancer or MEN-2 syndrome.

What should I do if I miss a dose of Mounjaro?

If a dose is missed, take it as soon as remembered within 4 days. If more than 4 days have passed, skip the missed dose and continue with the regular dosing schedule. Do not inject two doses within 3 days of each other.

How does Mounjaro interact with other medications?

Inform your healthcare provider about all medications, supplements, and herbal products you're taking. Mounjaro may interact with other diabetes medications like insulin or sulfonylureas, increasing the risk of hypoglycemia.

What are the storage instructions for Mounjaro?

Store Mounjaro in the refrigerator between 36°F to 46°F (2°C to 8°C). If needed, the single-dose pen can be stored at room temperature up to 86°F (30°C) for up to 21 days.

Who manufactures Mounjaro?

Mounjaro is manufactured and marketed by Eli Lilly and Company.

IMPORTANT NOTE: The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your healthcare professional for medical advice and treatment.

Product Code : 13917

SSL Certificate